Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 22 October

Bell Direct
October 22, 2025

Morning Bell 21 October

Bell Direct
October 21, 2025

Morning Bell 20 October

Bell Direct
October 20, 2025

Weekly Wrap 17 October

Bell Direct
October 17, 2025

Morning Bell 16 October

Bell Direct
October 16, 2025

Morning Bell 15 October

Bell Direct
October 15, 2025

Morning Bell 14 October

Bell Direct
October 14, 2025

Morning Bell 13 October

Bell Direct
October 13, 2025

Weekly Wrap 10 October

Bell Direct
October 10, 2025

Morning Bell 9 October

Bell Direct
October 9, 2025

Morning Bell 8 October

Bell Direct
October 8, 2025